Plasma GLP-1 levels are reported to be low in obese individuals with normal and impaired glucose tolerance (Hussein et al., 2014), and administration of native GLP-1 and GLP-1 agonists have been shown to reduce food intake and weight in obese humans (Näslund et al., 2004). Here, GLP1R is linked to Impaired glucose tolerance.